Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength
US9381166B2 · kind B2 · utility
3Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2008 |
| Grant date | Jul 5, 2016 |
| Priority date | — |
| Expiry date | Feb 3, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/9433
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel use and methods of treatment using sympathicomimetic agonists with pro-hemostatic activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.